04160 Observed and predicted effects of HMBS variants – results from the PredPor study

cutaneous pain and, in a minority of patients, liver failure.Approximately half of patients with protoporphyria have microcytic hypochromic anemia, which may be related to reduced iron availability or decreased heme biosynthesis.Several reports have described mild thrombocytopenia in patients with protoporphyria as well, though the mechanism for this remains unknown.In this study, we characterize the relationship between erythrocyte metal-free protoporphyrin IX (PPIX) levels, platelet count, and iron status in patients with protoporphyria.Methods We analyzed hematologic parameters in patients with protoporphyria treated at the Mass General Brigham (MGB) hospital system.Patient-level data across multiple time points were collected.Generalized Estimating Equation (GEE) models with an identity link and Gaussian family distribution were performed to determine the association, accounting for withinparticipant associations.A separate analysis was performed using linear regression for a cohort of patients with protoporphyria in Sweden, with one value per patient.Results A total of 118 patients with protoporphyria were included in the analysis including 65 patients from MGB and 53 from the Swedish cohort.In the MGB cohort, the median PPIX level was 1482 ug/dl (min 265-max 4897, ref <20).A 1mg/dl increase in PPIX was associated with a 0.02 x10 9 /L decrease in platelet count on average (p< 0.0001).This relationship was consistent when adjusting for alanine transaminase (ALT) and ferritin.There was no association between PPIX and ferritin (p = 0.57), PPIX and soluble transferrin receptor (p=0.31), or PPIX and hemoglobin (p =0.40).Higher PPIX levels were associated with lower MCV (p = 0.019) and higher ALT (p <0.0001).Similarly, in the Swedish cohort, a 1 mmol/L (ref <1.2) increase in PPIX was associated with a 1.4640 x10 9 /L decrease in platelet count (p = 0.01224), a relationship that remained consistent when adjusting for ALT and ferritin.PPIX was not significantly associated with hemoglobin (p=0.102),ferritin (p=0.352),MCV (p=0.063), or ALT (p=0.068), but the trends for MCV and ALT were present in the same direction as for the US cohort.Conclusion In this study of 118 patients with protoporphyria in the US and Sweden, we demonstrated a linear relationship between PPIX and platelet count that remained consistent when controlling for ALT and ferritin.The PPIX level was not associated with hemoglobin or markers of iron stores.Moving forward, we plan to present data for matched controls in the MGB cohort as well as data on the iron regulatory hormones, hepcidin and erythroferrone, in this group of patients.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/bmjgast-2024-icpp.89
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

04160 Observed and predicted effects of HMBS variants – results from the PredPor study

Aurora Martı́nez, Helene J. Bustad, Marthe S. Christie, Mikko Laitaoja et al.
Liver Disease Diagnosis and Treatment
article

04160 Observed and predicted effects of HMBS variants – results from the PredPor study

Aurora Martı́nez, Helene J. Bustad, Marthe S. Christie, Mikko Laitaoja, Aasne K. Aarsand, Janne Jänis, Janice Andersen, Jørild Haugen Villanger, Marte Høvik Hammersland, Juha P Kallio, Åshild Enes Rostad
article en

Abstract

cutaneous pain and, in a minority of patients, liver failure.Approximately half of patients with protoporphyria have microcytic hypochromic anemia, which may be related to reduced iron availability or decreased heme biosynthesis.Several reports have described mild thrombocytopenia in patients with protoporphyria as well, though the mechanism for this remains unknown.In this study, we characterize the relationship between erythrocyte metal-free protoporphyrin IX (PPIX) levels, platelet count, and iron status in patients with protoporphyria.Methods We analyzed hematologic parameters in patients with protoporphyria treated at the Mass General Brigham (MGB) hospital system.Patient-level data across multiple time points were collected.Generalized Estimating Equation (GEE) models with an identity link and Gaussian family distribution were performed to determine the association, accounting for withinparticipant associations.A separate analysis was performed using linear regression for a cohort of patients with protoporphyria in Sweden, with one value per patient.Results A total of 118 patients with protoporphyria were included in the analysis including 65 patients from MGB and 53 from the Swedish cohort.In the MGB cohort, the median PPIX level was 1482 ug/dl (min 265-max 4897, ref <20).A 1mg/dl increase in PPIX was associated with a 0.02 x10 9 /L decrease in platelet count on average (p< 0.0001).This relationship was consistent when adjusting for alanine transaminase (ALT) and ferritin.There was no association between PPIX and ferritin (p = 0.57), PPIX and soluble transferrin receptor (p=0.31), or PPIX and hemoglobin (p =0.40).Higher PPIX levels were associated with lower MCV (p = 0.019) and higher ALT (p <0.0001).Similarly, in the Swedish cohort, a 1 mmol/L (ref <1.2) increase in PPIX was associated with a 1.4640 x10 9 /L decrease in platelet count (p = 0.01224), a relationship that remained consistent when adjusting for ALT and ferritin.PPIX was not significantly associated with hemoglobin (p=0.102),ferritin (p=0.352),MCV (p=0.063), or ALT (p=0.068), but the trends for MCV and ALT were present in the same direction as for the US cohort.Conclusion In this study of 118 patients with protoporphyria in the US and Sweden, we demonstrated a linear relationship between PPIX and platelet count that remained consistent when controlling for ALT and ferritin.The PPIX level was not associated with hemoglobin or markers of iron stores.Moving forward, we plan to present data for matched controls in the MGB cohort as well as data on the iron regulatory hormones, hepcidin and erythroferrone, in this group of patients.

University of Eastern Finland (FI), Haukeland University Hospital (NO), University of Bergen (NO)
Zero hunger
Openalex Percentile: Top 76%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.